We dive deep into Alzheimer’s, Regeneron execs might be overpaid, a merger in clinical research, and the FDA issues a Class 1 recall Sponsorshttps://www.thescopemethod.com Story…
Pending FDA approvals, expanded FDA approvals, new FDA approvals, and a lawsuit about FDA approvals. Sponsorshttps://www.thescopemethod.com Story Referenceshttps://tinyurl.com/Niche-053-1https://tinyurl.com/Niche-053-2https://tinyurl.com/Niche-053-3https://tinyurl.com/Niche-053-4https://tinyurl.com/Niche-053-5https://tinyurl.com/Niche-053-6 Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodson The Niche Podcast…
M&A Speed Bumps, “Normal” IPO but not approach, two updates, and FDA gives nod to menstrual bleeding, prostate cancer, and COVID19 monoclonal antibodies. Sponsorshttps://www.thescopemethod.com Story…
Oncology on the move, an industry report looking at broader trends, good news in Alzheimer’s, and another niche oncology therapy approved. Sponsorshttps://www.thescopemethod.com Story Referenceshttps://tinyurl.com/Niche-051-1https://tinyurl.com/Niche-051-2https://tinyurl.com/Niche-051-3https://tinyurl.com/Niche-051-4https://tinyurl.com/Niche-051-5 Music…
Two FDA approvals, cellulite and tattoos, Ginkgo pulls in $2.5B, and Caris massive growth equity for oncology testing. Sponsorshttps://www.thescopemethod.com Story Referenceshttps://tinyurl.com/Niche-50-1https://tinyurl.com/Niche-50-2https://tinyurl.com/Niche-50-3https://tinyurl.com/Niche-50-4https://tinyurl.com/Niche-50-5https://tinyurl.com/Niche-50-6https://tinyurl.com/Niche-50-7 Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodson…
Critical intellectual property move by Biden-Harris, Pfizer goes for full approval, SPAC 1, SPAC 2, Regeneron drops big numbers, and an IPO gets punted. Sponsorshttps://www.thescopemethod.com…
Welcome to a monthly bonus episode. I sat down with Dr. Amir Kalali, the co-chair of the Decentralized Trials & Research Alliance (DTRA) – a…
The FDA slaps wrists and takes names, Farxiga expands FDA approval, BioVie makes cash-light acquisition, Pfizer targets fungus, and one IPO down, another to go.…
Billion-dollar amendments, billion-dollar funds, GSK gets oncology nod from FDA, and two stories in clinical research. Sponsorshttps://www.thescopemethod.com Story Referenceshttps://tinyurl.com/Niche-046-1https://tinyurl.com/Niche-046-2https://tinyurl.com/Niche-046-3https://tinyurl.com/Niche-046-4https://tinyurl.com/Niche-046-5 Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodson The Niche…
Massive acquisitions in the CRO space, Trodelvy 2x, diagnostic acquisitions, Merck closes COVID vaccine program, Xolair get’s self-injection nod, and tiny robots go for massive…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
